262 related articles for article (PubMed ID: 31903611)
1. Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management.
Feng Z; Rong P; Wang W
Hepatology; 2020 Jul; 72(1):361-362. PubMed ID: 31903611
[No Abstract] [Full Text] [Related]
2. Letter to the Editor: Consider More Factors When Studying Risk of Cirrhosis and Hepatocellular Cancer in Patients With Nonalcoholic Fatty Liver Disease.
Yang NB; Li GX; Chu JG; Wang YJ
Hepatology; 2020 Jun; 71(6):2172-2173. PubMed ID: 31849080
[No Abstract] [Full Text] [Related]
3. Letter to the Editor: The Association Between Diabetes and Hepatocellular Carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver Disease.
Tantai X; Liu N; Wang J
Hepatology; 2020 Jul; 72(1):363-364. PubMed ID: 31904864
[No Abstract] [Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Massoud O; Charlton M
Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
[TBL] [Abstract][Full Text] [Related]
5. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.
Marengo A; Jouness RI; Bugianesi E
Clin Liver Dis; 2016 May; 20(2):313-24. PubMed ID: 27063271
[TBL] [Abstract][Full Text] [Related]
6. [Hepatocellular carcinoma].
Czauderna C; Marquardt JU; Galle PR; Wörns MA
Internist (Berl); 2017 May; 58(5):469-479. PubMed ID: 28386626
[TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.
Phan J; Ng V; Sheinbaum A; French S; Choi G; El Kabany M; Durazo F; Saab S; Tong M; Busuttil R; Han SH
J Clin Gastroenterol; 2019 Apr; 53(4):309-313. PubMed ID: 29912756
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis.
Tovo CV; de Mattos AZ; Coral GP; Sartori GDP; Nogueira LV; Both GT; Villela-Nogueira CA; de Mattos AA
World J Gastroenterol; 2023 Jan; 29(2):343-356. PubMed ID: 36687125
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey.
Cotrim HP; Oliveira CP; Coelho HS; Alvares-da-Silva MR; Nabuco L; Parise ER; Ivantes C; Martinelli AL; Galizzi-Filho J; Carrilho FJ
Clinics (Sao Paulo); 2016 May; 71(5):281-4. PubMed ID: 27276398
[TBL] [Abstract][Full Text] [Related]
10. Women with Cirrhosis: Prevalence, Natural History, and Management.
Giard JM; Terrault NA
Gastroenterol Clin North Am; 2016 Jun; 45(2):345-58. PubMed ID: 27261903
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
[TBL] [Abstract][Full Text] [Related]
12. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.
Stine JG; Wentworth BJ; Zimmet A; Rinella ME; Loomba R; Caldwell SH; Argo CK
Aliment Pharmacol Ther; 2018 Oct; 48(7):696-703. PubMed ID: 30136293
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease.
Yang JD; Ahmed F; Mara KC; Addissie BD; Allen AM; Gores GJ; Roberts LR
Hepatology; 2020 Mar; 71(3):907-916. PubMed ID: 31309602
[TBL] [Abstract][Full Text] [Related]
14. Reply to: "Polygenic risk score: A promising predictor for hepatocellular carcinoma in the population with non-alcoholic fatty liver disease".
Jamialahmadi O; Bianco C; Pelusi S; Romeo S; Valenti L
J Hepatol; 2021 Jun; 74(6):1494-1496. PubMed ID: 33676949
[No Abstract] [Full Text] [Related]
15. Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study.
Xiong J; Wang J; Huang J; Sun W; Wang J; Chen D
Clinics (Sao Paulo); 2015 Aug; 70(8):563-8. PubMed ID: 26247669
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma and non-alcoholic fatty liver disease.
Golabi P; Rhea L; Henry L; Younossi ZM
Hepatol Int; 2019 Nov; 13(6):688-694. PubMed ID: 31701393
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
Dhamija E; Paul SB; Kedia S
Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence and harm of nonalcoholic fatty liver disease].
Shao YL; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):10-13. PubMed ID: 30685917
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
20. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
Zhu C; Zhou D; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
